www.cpexpharm.com
HOME
COMPANY PROFILE
MANAGEMENT
INVESTOR RELATIONS
OVERVIEW
CORPORATE GOVERNANCE
STOCK TRANSFER AGENT
SEC FILINGS
SECTION 16 FORMS
PRESENTATIONS/EVENTS
PUBLICATIONS
 PRESS RELEASES
ANNUAL REPORTS
CONTACT

 
 
To view our documents, you must use PDF software.
All documents are compatible with Adobe® v6.0 and higher.
Get Acrobat Reader
[ 2010 | 2009 | 2008 ]

AUGUST 09, 2010
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2010 FINANCIAL RESULTS

MAY 26, 2010
CPEX PHARMACEUTICALS SHAREHOLDERS ELECT ROBERT FORRESTER TO BOARD OF DIRECTORS

MAY 06, 2010
CPEX PHARMACEUTICALS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT TENDER OFFER ANNOUNCED BY RICHARD ROFÉ

MAY 05, 2010
CPEX PHARMACEUTICALS REPORTS FIRST-QUARTER 2010 FINANCIAL RESULTS

APRIL 30, 2010
CPEX PHARMACEUTICALS APPOINTS ROBERT FORRESTER TO BOARD OF DIRECTORS

APRIL 23, 2010
CPEX PHARMACEUTICALS ADVISES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPONSE TO ARCADIA UNSOLICITED TENDER OFFER

APRIL 12, 2010
CPEX PHARMACEUTICALS ISSUES OPEN LETTER TO SHAREHOLDERS

APRIL 01, 2010
CPEX PHARMACEUTICALS’ PARTNER ANNOUNCES DEVELOPMENT AND COMMERCIALIZATION AGREEMENT WITH ALLERGAN FOR NOCTURIA PRODUCT CANDIDATE

MARCH 18, 2010
CPEX PHARMACEUTICALS FILES PRELIMINARY PROXY MATERIALS AND NOMINATES HIGHLY QUALIFIED INDEPENDENT BOARD CANDIDATE FOR ELECTION AT 2010 ANNUAL MEETING

MARCH 17, 2010
CPEX PHARMACEUTICALS ANNOUNCES PRELIMINARY RESULTS FROM ITS PHASE 2A CLINICAL TRIAL OF NASULIN™

MARCH 03, 2010
CPEX PHARMACEUTICALS REPORTS 2009 FOURTH-QUARTER AND YEAR-END FINANCIAL RESULTS

FEBRUARY 18, 2010
CPEX PHARMACEUTICALS ANNOUNCES ARCADIA OPPORTUNITY MASTER FUND WITHDRAWS PREVIOUSLY STATED INTENTION TO SUBMIT SHAREHOLDER PROPOSALS AND NOMINATE DIRECTOR SLATE AT 2010 ANNUAL MEETING

ARCADIA RETAINS INTENT TO NOMINATE ONE DIRECTOR

FEBRUARY 01, 2010
CPEX PHARMACEUTICALS ANNOUNCES APPOINTMENT OF NEW CHIEF SCIENTIFIC OFFICER

JANUARY 08, 2010
CPEX PHARMACEUTICALS REPORTS ON SEC FILING BY ARCADIA CAPITAL ADVISORS

If you are interested in receiving an investor packet, please call us at 603.658.6100.

 
 
 
AUGUST 09, 2010
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2010 FINANCIAL RESULTS
 
MAY 26, 2010
CPEX PHARMACEUTICALS SHAREHOLDERS ELECT ROBERT FORRESTER TO BOARD OF DIRECTORS
 
MAY 06, 2010
CPEX PHARMACEUTICALS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT TENDER OFFER ANNOUNCED BY RICHARD ROFÉ
 

P I P E L I N E
 
P A R T N E R I N G
 
F A C T   S H E E T
 
 
[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]
 
CPEX PHARMACEUTICALS, INC.
2 HOLLAND WAY
EXETER NH 03833

TEL: 603.658.6100
FAX: 603.658.6101